Home
Home

The Capital Royalty team has extensive healthcare, private equity, investment banking, and capital markets experience, and, together, is responsible for the most significant innovations in the royalty investment industry since its inception in 1995. Members of our team were the first to identify investing in biopharmaceutical royalties as a discreet investment strategy, the first to structure a revenue interest transaction, and developed the first royalty bonds for pharmaceutical companies. Today, we continue to create innovative structures to meet the financing needs of our clients.

CHARLES TATE - Chairman and Founding Partner

Charles Tate founded Capital Royalty in 2003 after a successful 35-year career in investment banking and private equity. Before launching Capital Royalty, Mr. Tate was a Partner and Executive Committee Member of Hicks, Muse, Tate & Furst from 1991 to 2002 and for 19 years was at Morgan Stanley & Co. —11 years as a Managing Director in both its M&A and merchant banking divisions.


NATHAN HUKILL - Managing Director

Nathan Hukill joined Capital Royalty in 2009, bringing more than 11 years of investing and transaction structuring experience. Prior to joining Capital Royalty, Mr. Hukill was a Portfolio Manager at Highland Capital Management, L.P., where he invested and managed approximately $4.5 billion in alternative assets in the healthcare, consumer products, and technology sectors.


SIDNEY TAUREL - Senior Advisor

Sidney Taurel is Chairman Emeritus of Eli Lilly and Company. Mr. Taurel joined Eli Lilly and Company in 1971 and worked at the company for 37 years, 15 of which were spent on international assignments based in Sao Paulo, Vienna, Paris, and London.


MICHAEL WEINMANN - Managing Director

Michael Weinmann joined Capital Royalty in 2009 and opened the firm’s New York office. Mr. Weinmann has 11 years of capital markets and mergers and acquisitions experience, most recently as an Executive Director in Morgan Stanley’s Global Capital Markets division, specializing in structured debt financings and intellectual property monetizations.


LUKE DUSTER - Principal

Luke Düster joined Capital Royalty in 2009, bringing more than 10 years of mergers and acquisitions experience. Most recently, Mr. Düster was a Vice President at Harris Williams & Co., where he advised private equity and corporate clients across a broad spectrum of industries.


DAVID CARTER - Principal

David Carter joined Capital Royalty in 2003, bringing more than 20 years of investment experience. Prior to joining Capital Royalty, Mr. Carter was a Partner at Palestra Capital, a New York-based hedge fund, where he focused on risk arbitrage, special situations, and distressed securities.


HARRY LOVEYS - Principal

Harry Loveys helped found Capital Royalty in 2003, bringing more than 25 years of experience in the pharmaceutical industry. Before Capital Royalty, Mr. Loveys was the Executive Vice President of Drug Royalty Corporation, the first public royalty investment company.


PETER FARONI - Associate

Peter Faroni joined Capital Royalty in 2010, bringing four years of investing and capital markets experience at Morgan Stanley & Co. Most recently, Mr. Faroni worked as an associate in Morgan Stanley’s Special Situations group in the Fixed Income division, where he focused on distressed debt and event-driven credit investing.


ANDREI DORENBAUM - Executive Director and General Counsel

Andrei Dorenbaum joined Capital Royalty in 2010. Previously, Mr. Dorenbaum was an assistant general counsel at Highland Capital Management, L.P., a registered investment advisor with over $20 billion under management.


FRANK GIROLAMO - Chief Compliance Officer

Frank Girolamo joined Capital Royalty in 2006. Prior to Capital Royalty, Mr. Girolamo spent more than 30 years in the chemical industry, holding positions in domestic and international sales and marketing management, business line leadership, and manufacturing.


MARY BOGUE LOGAN - Chief Financial Officer

Mary Bogue Logan joined Capital Royalty in 2006. Prior to Capital Royalty, Ms. Logan was the Chief Financial Officer of Avail Consulting, LLC, a Houston-based company specializing in valuation and appraisal services.


COURTNEY GROBE - Accounting Manager

Ms. Grobe joined Capital Royalty in June of 2005. Prior to joining Capital Royalty, Ms. Grobe worked as an audit professional at Deloitte & Touche, where her two largest clients were in the manufacturing and healthcare industries.